Robotic Flight Simulator Surgery Market Report 2026

The robotic flight simulator surgery market size has grown rapidly in recent years. It will grow from $0.78 billion in 2025 to $0.87 billion in 2026 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to growth in surgical training complexity, expansion of simulation based education, rising patient safety focus, increase in minimally invasive surgery, development of high fidelity simulators.

The robotic flight simulator surgery market size is expected to see rapid growth in the next few years. It will grow to $1.36 billion in 2030 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to higher adoption of vr surgical labs, growth in competency based surgical certification, expansion of remote surgical training, rising demand for rehearsal based planning, increased funding for medical simulation centers. Major trends in the forecast period include growth in virtual surgical training platforms, rising use of patient specific procedure simulation, expansion of haptic enabled training systems, increasing adoption of team based surgical simulation, integration of performance scoring and feedback tools.

The increasing complexity of surgical procedures is anticipated to propel the growth of the robotic flight simulator surgery market in the coming years. Surgical procedures are medical operations performed by trained surgeons to treat diseases, injuries, or deformities through physical alteration of body tissues. The complexity of surgical procedures is rising due to aging populations, a growing prevalence of chronic conditions requiring surgical intervention, and the expanding adoption of minimally invasive and robot-assisted surgical techniques. Robotic flight simulator surgery supports surgical training by allowing surgeons to practice complex procedures in a realistic virtual environment, enhance technical skills, and improve procedural preparedness prior to live operations. For instance, in April 2025, according to the Australian Institute of Health and Welfare (AIHW), an Australia-based independent statutory agency, public hospital elective surgery admissions reached 778,500, reflecting a 5.8% increase from 735,500 in 2022-23. Therefore, the growing complexity of surgical procedures is driving the growth of the robotic flight simulator surgery market.

Key companies operating in the robotic flight simulator surgery market are focusing on the integration of artificial intelligence (AI) within simulation platforms, such as the VTVR platform, to enhance surgical precision, optimize training outcomes, and provide real-time performance analytics for both novice and experienced surgeons. The VTVR platform most commonly refers to a virtual reality-based training platform used in the context of CMR Surgical’s Versius robotic surgery training program. For example, in July 2023, CMR Surgical, a UK-based surgical robotics company, introduced the Versius Trainer in VR (VTVR), a cutting-edge virtual reality simulator for its Versius robotic surgical system. The VTVR enables surgeons to engage in interactive simulator exercises through VR headsets and hand controllers, offering flexible anywhere, anytime training. Designed to complement the existing Versius Trainer, it delivers a wireless and portable experience without the need for a PC connection. This innovative approach helps surgeons practice and familiarize themselves with the Versius interface at their own pace. By providing this accessible, immersive training, VTVR can accelerate skill development and shorten the traditional learning curve compared with in-lab simulator use.

In February 2023, EnQuest Robotics, a US-based company focused on enabling minimally invasive “scar-free” surgeries, partnered with VirtaMed. Through this collaboration, EndoQuest Robotics and VirtaMed aim to develop an advanced endoluminal robotic training simulator that provides surgeons with a realistic, risk-free environment for mastering robotic-assisted procedures. VirtaMed is a Switzerland-based company that provides advanced, high-fidelity virtual reality (VR) simulation solutions for robotic-assisted surgery.

Major companies operating in the robotic flight simulator surgery market are Medtronic plc, Intuitive Surgical Inc., Smith & Nephew plc, CAE Inc., Meerecompany Inc., Surgical Science Sweden AB, Avatera Medical GmbH, CMR Surgical Ltd, Osso VR, Ubitus K.K., Mentice AB, HaptX Inc., KRN Labs, Medicaroid Corporation, PrecisionOS Technology, EndoQuest Robotics Inc., iotaMotion Inc., LifeLike BioTissues, ToLTech GmbH, Simulated Surgical Systems LLC.

Tariffs on VR hardware, robotic training consoles, and haptic feedback devices are increasing system costs in the robotic flight simulator surgery market. Import duties on visualization systems and simulation processors are affecting procurement budgets for training centers and hospitals. North america and asia pacific institutions relying on imported simulation equipment are most affected. Orthopedic, cardiac, and neurosurgery simulation segments face higher pricing due to advanced hardware needs. At the same time, tariffs are encouraging local assembly of simulation platforms and regional supplier ecosystems. Training providers are sourcing more components domestically. This strengthens local supply chains while raising near term setup costs.

The robotic flight simulator surgery market research report is one of a series of new reports that provides robotic flight simulator surgery market statistics, including robotic flight simulator surgery industry global market size, regional shares, competitors with a robotic flight simulator surgery market share, detailed robotic flight simulator surgery market segments, market trends and opportunities, and any further data you may need to thrive in the robotic flight simulator surgery industry. This robotic flight simulator surgery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Robotic flight simulator surgery involves the application of advanced robotic platforms together with high-fidelity virtual reality environments similar to flight simulators to train, plan, and rehearse surgical procedures in a realistic and risk-free setting, allowing surgeons to practice complex techniques, strengthen coordination, and refine clinical decision-making before actual operations. It also supports patient-specific simulation by using medical imaging data to generate customized virtual models, helping improve surgical strategies, increase precision, lower errors, and enhance clinical outcomes.

The key surgery types for robotic flight simulator surgery include cardiac surgery, orthopedic surgery, neurosurgery, gastrointestinal surgery, urological surgery, and other types. Cardiac surgery refers to simulated robotic training and planning systems specifically developed for heart-related procedures to improve precision and reduce risks. These solutions employ technologies such as virtual reality (VR), augmented reality (AR), and mixed reality (MR), and are used across applications including training and education, preoperative planning, surgical navigation, and rehabilitation or recovery training. End-users include hospitals, clinics, ambulatory surgical centers (ASCs), and research or academic institutions.

The robotic flight simulator surgery market consists of revenues earned by entities by providing services such as virtual surgical training and skill development, preoperative surgical planning and rehearsal, patient-specific procedure simulation, surgical performance assessment and feedback, and team-based surgical workflow training. The market value includes the value of related goods sold by the service provider or included within the service offering. The robotic flight simulator surgery market also includes sales of robotic surgical training consoles, virtual reality simulators, haptic-enabled training tools, three-dimensional visualization systems, procedural simulation software, and performance assessment modules. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.